What is the recommended outpatient primary care management for a patient recently discharged from the emergency department with heart failure and hypertension, including medication adjustments and monitoring?

Post-ER Heart Failure and Hypertension Management

For patients recently discharged from the emergency department with heart failure and hypertension, continue or initiate guideline-directed medical therapy (GDMT) including ACE inhibitors/ARBs, beta-blockers, and aldosterone antagonists, optimize diuretic dosing to achieve euvolemia, and schedule follow-up within 7-14 days with close monitoring of volume status, blood pressure, renal function, and electrolytes. 1, 2

Immediate Post-Discharge Medication Management

Continue or Initiate GDMT

• Continue all GDMT medications (ACE inhibitors/ARBs, beta-blockers, aldosterone antagonists) that were started in hospital unless hemodynamic instability or contraindications exist 1, 3
• If not already on GDMT, initiate these medications before or immediately after discharge - this is associated with reduced 1-year mortality 3, 4
• Beta-blockers should be initiated at low doses only after volume optimization and discontinuation of IV agents 1, 3

Diuretic Optimization

Critical for preventing readmission:

• Transition from IV to oral loop diuretics with the discharge dose equal to or exceeding the chronic oral daily dose 1
• Most commonly: furosemide 20-40 mg once or twice daily initially, torsemide 10-20 mg once daily, or bumetanide 0.5-1.0 mg once or twice daily 1
• Provide a clear plan for diuretic adjustment based on daily weights 1, 4
• Goal: eliminate all clinical evidence of fluid retention before discharge 1

Common pitfall: Discharging patients with persistent congestion increases mortality and readmission risk - ensure complete decongestion before discharge 5, 4

Monitoring Protocol

First Post-Discharge Visit (Within 7-14 Days)

Essential assessments: 1, 2

1. Volume status evaluation:

   • Daily weights (instruct patient to weigh at same time daily)
   • Assess for peripheral edema, jugular venous distension, orthopnea
   • Adjust diuretics if weight increases >2-3 lbs in 1 day or >5 lbs in 1 week

2. Blood pressure monitoring:

   • Check both supine and upright BP to detect orthostatic hypotension
   • Target BP <130/80 mmHg while avoiding symptomatic hypotension
   • Adjust vasodilators/diuretics if hypotension occurs

3. Laboratory monitoring:

   • Serum electrolytes (potassium, sodium)
   • Renal function (creatinine, BUN)
   • Target potassium 4.0-5.0 mmol/L 6
   • Do not prematurely discontinue diuresis for small creatinine elevations (<0.3 mg/dL) if congestion persists 4

4. Medication reconciliation and optimization:

   • Titrate beta-blockers toward target doses (bisoprolol 10 mg, metoprolol succinate 200 mg, carvedilol 50 mg, nebivolol 10 mg) over weeks to months 7, 8
   • Start with very low doses and double every 1-2 weeks if tolerated 7, 8
   • Optimize ACE inhibitor/ARB dosing

Beta-Blocker Titration Strategy

Follow this structured approach: 7, 8

• Patient must be on background ACE inhibitor therapy
• Ensure relative stability without IV inotropes or marked fluid retention
• If worsening symptoms occur: First increase diuretics or ACE inhibitor dose; temporarily reduce beta-blocker only if necessary
• If hypotension occurs: First reduce vasodilator doses; reduce beta-blocker only if necessary
• If bradycardia occurs: Reduce or discontinue other rate-lowering drugs first; reduce beta-blocker dose only if clearly necessary
• Always attempt reintroduction/uptitration when patient stabilizes

Hypertension Management Considerations

For patients with both HF and hypertension:

• ACE inhibitors/ARBs serve dual purpose - treating both HF and hypertension 7, 1
• ARBs are appropriate alternatives if ACE inhibitor intolerant 7
• Avoid calcium channel blockers except vasoselective agents (amlodipine, felodipine) 6
• Avoid NSAIDs - they cause sodium retention and attenuate diuretic/ACE inhibitor efficacy 6

Patient Education and Self-Management

Provide written discharge instructions covering: 3

• Daily weight monitoring with specific thresholds for calling provider
• Dietary sodium restriction (typically 2-3 grams daily)
• Fluid restriction if hyponatremic
• Medication adherence and importance of uptitration
• Warning signs of worsening HF (increased dyspnea, weight gain, edema)
• Emergency action plan

Follow-Up Schedule

• Telephone contact within 3 days of discharge 1, 2
• Office visit within 7-14 days 1, 2
• Subsequent visits every 1-2 weeks during medication titration
• Once stable, follow-up every 3-6 months with laboratory monitoring 8

High-Risk Patient Identification

Consider multidisciplinary HF disease-management program referral for patients at high readmission risk 1, 2:

• Severe HF (NYHA Class III/IV)
• Multiple prior hospitalizations
• Significant comorbidities
• Poor social support
• Medication non-adherence

Critical caveat: Nearly 42% of HF patients receive no GDMT within 30 days post-discharge, and 45% receive no GDMT or monotherapy within 1 year 5, 4. Do not assume medications will be optimized later - initiate and uptitrate aggressively during early post-discharge period.